Main page content

Displaying results 1 - 10 of 96
Publication ID: PEP24-03-001
Published:
SAMHSA’s updated Overdose Prevention and Response Toolkit provides guidance to a wide range of individuals on preventing and responding to an overdose. The toolkit also emphasizes that harm reduction and access to treatment are essential aspects of overdose prevention.
Publication ID: PEP23-03-00-001
Published:
SAMHSA’s updated Overdose Prevention and Response Toolkit provides guidance to a wide range of individuals on preventing and responding to an overdose. The toolkit also emphasizes that harm reduction and access to treatment are essential aspects of overdose prevention.
Publication ID: PEP22-01-01-003
Published:

This guide offers information and tips to disaster responders and first responders to help them manage stress during crisis response. It describes how stress affects the body and suggests ways for individuals and organizations to promote and engage in stress management.

Publication ID: PEP21-06-01-002
Published:

This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.

Publication ID: PEP21-01-01-002
Published:

This brochure features the national Disaster Distress Helpline, which supports people who are coping with the after effects of a disaster. Learn about a disasters’ potential to cause psychological stress, warning signs of distress, and tips for coping.

Publication ID: PEP21-01-01-001
Published:

This wallet-size card includes the national Disaster Distress Helpline and lists warning signs of distress. It encourages those experiencing signs of psychological stress to call or text the helpline for support.

Publication ID: PEP21-02-01-003
Published:

The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.

Publication ID: PEP21-02-01-002
Published:

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.

Publication ID: PEP21-06-02-001
Published:

This guide reviews ways that telehealth modalities can be used to provide treatment for serious mental illness and substance use disorders among adults, distills the research into recommendations for practice, and provides examples of how these recommendations can be implemented.

Publication ID: PEP20-01-01-025
Published:
Re-traumatization is when stress reactions experienced as a result of a previous traumatic event are relived when faced with a new similar incident. However, as time passes, many people do not realize that the stress they are feeling is related to the previous traumatic experience.

Displaying 1 - 10 out of 96